Skip to main navigationSkip to main content
The University of Southampton
Southampton Health Technology Assessments Centre

Haemochromatosis

Click on the title for more information (where available).

Bryant J, Cooper K, Picot J, Clegg AJ, Roderick P, Rosenberg W et al. Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation. Health Technology Assessment 2009;13(23):1-148.  

Picot J, Bryant J, Cooper K, Clegg A, Roderick P, Rosenberg W et al. Psychosocial Aspects of DNA Testing for Hereditary Hemochromatosis in At-Risk Individuals: A Systematic Review. Genetic testing and molecular biomarkers 2009;13(1):7-14.  

Bryant J, Cooper K, Picot J, Clegg A, Roderick P, Rosenberg W et al. A systematic review of the clinical validity and clinical utility of DNA testing for hereditary haemochromatosis type 1 in at-risk populations. Journal of Medical Genetics 2008;45(8):513-8.

Cooper K, Bryant J, Picot J, Clegg A, Roderick PR, Rosenberg WM et al. A decision analysis model for diagnostic strategies using DNA testing for hereditary haemochromatosis in at risk populations. QJM 2008;101(8):631-41.                                    

Cooper K, Bryant J, Picot J, Roderick P, Patch C, Clegg A, and Rosenberg W. Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations. Health Technology Assessment International IV Annual Meeting HTAi, 17-20 June, 2007. 2007. 

Patch C, Bryant J, Cooper K, Picot J, Roderick P, Rosenberg W, and Clegg A. Decision models evaluating genetic testing in Haemochromatosis: a multidisciplinary collaboration. European Society of Human Genetics European Human Genetics Conference, June 16-19, 2007. 2007.  

Privacy Settings